Literature DB >> 15321720

NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex.

Yibing Wu1, Padmanava Pradhan, Jody Havener, Gunnar Boysen, James A Swenberg, Sharon L Campbell, Stephen G Chaney.   

Abstract

We have determined, at high resolution, the NMR solution structure of an oxaliplatin-GG DNA dodecamer in the AGGC sequence context by 2D NMR studies. Homonuclear assignment strategies resulted in unambiguous assignment of 203 out of 249 protons, which corresponds to assignment of approximately 81% of the protons. Assignments of H5' and H5" protons were tentative due to resonance overlap. The structure of the oxaliplatin duplex was calculated using the program CNS with a simulated annealing protocol. A total of 510 experimental restraints were employed in the structure calculation. Of 20 calculated structures, the 15 with the lowest energy were accepted as a family. The RMSD of the 15 lowest energy structures was 0.68 A, indicating good structural convergence. The theoretical NOESY spectrum obtained by back-calculation from the final average structure showed excellent agreement with the experimental data, indicating that the final structure was in good agreement with the experimental NMR data. Significant conformational differences were observed between the oxaliplatin-GG 12-mer DNA we studied and all previous solution structures of cisplatin-GG DNA duplexes. For example, the oxaliplatin-GG adduct shows much less distortion at the AG base-pair step than the cisplatin-GG adducts. In addition, the oxaliplatin-GG structure also has a narrow minor groove and an overall axis bend of about 31 degrees, both of which are very different from the recent NMR structures for the cisplatin-GG adducts. These structural differences may explain some of the biological differences between oxaliplatin- and cisplatin-GG adducts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15321720     DOI: 10.1016/j.jmb.2004.06.066

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.

Authors:  C L King; S Ramachandran; S G Chaney; L Collins; J A Swenberg; K E DeKrafft; W Lin; L Cicurel; M Barbier
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

2.  Structural studies on ligand-DNA systems: A robust approach in drug design.

Authors:  Surat Kumar; Prateek Pandya; Kumud Pandav; Surendra P Gupta; Arun Chopra
Journal:  J Biosci       Date:  2012-07       Impact factor: 1.826

3.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Non-specificity and synergy at the binding site of the carboplatin-induced DNA adduct via molecular dynamics simulations of the MutSα-DNA recognition complex.

Authors:  Lacramioara Negureanu; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2013-06-25

5.  Computational evidence for structural consequences of kiteplatin damage on DNA.

Authors:  Shaun T Mutter; Nicola Margiotta; Paride Papadia; James A Platts
Journal:  J Biol Inorg Chem       Date:  2014-11-07       Impact factor: 3.358

6.  Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.

Authors:  Hala Ouzon-Shubeita; Meghan Baker; Myong-Chul Koag; Seongmin Lee
Journal:  Biochem J       Date:  2019-02-28       Impact factor: 3.857

7.  Solution structures of a DNA dodecamer duplex with and without a cisplatin 1,2-d(GG) intrastrand cross-link: comparison with the same DNA duplex containing an oxaliplatin 1,2-d(GG) intrastrand cross-link.

Authors:  Yibing Wu; Debadeep Bhattacharyya; Candice L King; Irene Baskerville-Abraham; Sung-Ho Huh; Gunnar Boysen; James A Swenberg; Brenda Temple; Sharon L Campbell; Stephen G Chaney
Journal:  Biochemistry       Date:  2007-05-12       Impact factor: 3.162

Review 8.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

9.  Molecular dynamic simulations of cisplatin- and oxaliplatin-d(GG) intrastand cross-links reveal differences in their conformational dynamics.

Authors:  Shantanu Sharma; Peng Gong; Brenda Temple; Debadeep Bhattacharyya; Nikolay V Dokholyan; Stephen G Chaney
Journal:  J Mol Biol       Date:  2007-08-23       Impact factor: 5.469

Review 10.  Inhibition of transcription by platinum antitumor compounds.

Authors:  Ryan C Todd; Stephen J Lippard
Journal:  Metallomics       Date:  2009       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.